Prosecution Insights
Last updated: October 02, 2026

Examiner: BIBBEE, JARED M

Tech Center 2100 • Art Units: 2161 2174

This examiner grants 80% of resolved cases

Analysis

Jared M. Bibbee is an examiner in Tech Center 2100, specifically within Art Unit 2161. The examiner has 674 resolved cases on record. These 674 resolved cases result in an allowance rate of 80.3 percent. This 80.3 percent allowance rate serves as a metric for practitioners evaluating their chances of success. Understanding this rate is a component of setting expectations during the stages of patent prosecution.

The median days to allowance for Bibbee is 1101. This 1101-day timeline provides a measure of the duration required to reach a grant. Practitioners should also consider the 13.7 percent interview lift. An interview lift of 13.7 percent suggests that engaging in a direct discussion with the examiner is associated with an increased probability of allowance. This 13.7 percent lift is a factor to include in prosecution planning.

In Art Unit 2161, the 1101 median days to allowance and 80.3 percent allowance rate define the examiner's historical performance. The 13.7 percent interview lift indicates that interviews are a tool for applicants. With 674 resolved cases, the data provides a specific statistical context for Tech Center 2100. Practitioners can use these figures to refine their approach and manage client expectations regarding the 1101-day median timeline.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

80.3%
Allow Rate
+25.3% vs TC avg
682
Total Applications
+13.7%
Interview Lift
1099
Avg Prosecution Days
Based on 674 resolved cases, 2023–2026

Rejection Statute Breakdown

15.9%
§101 Eligibility
17.7%
§102 Novelty
52.3%
§103 Obviousness
4.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18919086 METHOD AND SYSTEM FOR STORING MEASUREMENT DATA DETECTED BY A SENSOR DEVICE AND INDICATIVE OF AN ANALYTE IN A SAMPLE OF A BODILY FLUID Final Rejection Roche Diabetes Care, Inc.
19254831 INSTRUCTION INDUCTION FOR NL2SQL PROMPTS AND GENERATIVE MODELS Non-Final OA Oracle International Corporation
19245897 PREDICTION OF CACHEABLE QUERIES Final Rejection ADP, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month